ECSP088466A - Compuesto de cinamida biciclico - Google Patents

Compuesto de cinamida biciclico

Info

Publication number
ECSP088466A
ECSP088466A EC2008008466A ECSP088466A ECSP088466A EC SP088466 A ECSP088466 A EC SP088466A EC 2008008466 A EC2008008466 A EC 2008008466A EC SP088466 A ECSP088466 A EC SP088466A EC SP088466 A ECSP088466 A EC SP088466A
Authority
EC
Ecuador
Prior art keywords
group
optionally substituted
cinamide
bicycle
composite
Prior art date
Application number
EC2008008466A
Other languages
English (en)
Inventor
Teiji Kimura
Koki Kawano
Eriko Doi
Noritaka Kitazawa
Mamoru Takaishi
Koichi Ito
Toshihiko Kaneko
Takeo Sasaki
Takehiko Miyagawa
Hiroaki Hagiwara
Yu Yoshida
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of ECSP088466A publication Critical patent/ECSP088466A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto de cinamida bicíclico representado por la Fórmula general (I):en donde ---- representa un enlace sencillo o un enlace doble; Ar1 representa un grupo fenilo o grupo piridinilo opcionalmente substituido por uno hasta tres substituyentes; R1 y R2 cada uno representa un grupo alquilo C1-6, un grupo hidroxilo, etc.; Z1 representa un grupo metileno opcionalmente substituido o grupo vinileno, un átomo de oxígeno, o un grupo imino opcionalmente substituido por un grupo alquilo C1-6 o un grupo acilo C1-6; y p, q, y r cada uno es un entero de 0 hasta 2. Funciona para reducir Ab40 y Ab42. Por lo tanto útil especialmente como una prevención o remedio para enfermedades neurodegenerativas de las cuales Ab es el causante, tal como enfermedad de Alzheimer y síndrome de Down.
EC2008008466A 2005-11-24 2008-05-22 Compuesto de cinamida biciclico ECSP088466A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005337963 2005-11-24
JP2006205538 2006-07-28

Publications (1)

Publication Number Publication Date
ECSP088466A true ECSP088466A (es) 2008-08-29

Family

ID=38067057

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008466A ECSP088466A (es) 2005-11-24 2008-05-22 Compuesto de cinamida biciclico

Country Status (25)

Country Link
US (1) US8048878B2 (es)
EP (1) EP1953158B1 (es)
JP (1) JP5178203B2 (es)
KR (1) KR101296239B1 (es)
AR (1) AR057915A1 (es)
AU (1) AU2006317468B2 (es)
BR (1) BRPI0618890A2 (es)
CA (1) CA2629512C (es)
CR (1) CR9983A (es)
EA (1) EA014427B1 (es)
EC (1) ECSP088466A (es)
ES (1) ES2394364T3 (es)
GE (1) GEP20115172B (es)
HN (1) HN2008000792A (es)
MA (1) MA29968B1 (es)
ME (1) ME00040B (es)
MY (1) MY144596A (es)
NO (1) NO20082805L (es)
NZ (1) NZ568422A (es)
PE (1) PE20071029A1 (es)
PL (1) PL1953158T3 (es)
RS (1) RS20080242A (es)
SA (1) SA06270432B1 (es)
TW (1) TWI370130B (es)
WO (1) WO2007060821A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361872C2 (ru) * 2004-05-26 2009-07-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Циннамидное соединение
DE602005019602D1 (de) 2004-10-26 2010-04-08 Eisai R&D Man Co Ltd Amorphe form einer zimtsäureamidverbindung
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
KR20080069221A (ko) 2005-11-24 2008-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 모르폴린 타입의 신나미드 화합물
US7482345B2 (en) * 2005-12-05 2009-01-27 Meng-Hsin Chen P38 kinase inhibiting agents
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US7737141B2 (en) 2006-07-28 2010-06-15 Eisai R&D Management Co., Ltd. Prodrug of cinnamide compound
CL2008000582A1 (es) 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
CA2689948A1 (en) * 2007-06-01 2008-12-18 Schering Corporation Gamma secretase modulators
JP5121346B2 (ja) * 2007-08-07 2013-01-16 国立大学法人 長崎大学 光学活性プロリンエステル誘導体およびｎ−ホルミル光学活性プロリン誘導体の製造方法
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
BRPI0815773A2 (pt) 2007-08-31 2019-09-24 Eisai R&D Man Co Ltd composto, e, medicamento.
EP2226325A4 (en) * 2007-12-26 2010-12-29 Eisai R&D Man Co Ltd PROCESS FOR THE PRODUCTION OF 4- (PHENYL-SUBSTITUTED) HEXAHYDROPYRIDOÝ2,1-CÝÝ1,4¨OXAZIN-6-ONE
JP5328816B2 (ja) 2008-02-22 2013-10-30 エフ．ホフマン−ラ ロシュ アーゲー アミロイドβの調節薬
WO2010040661A1 (en) 2008-10-09 2010-04-15 F. Hoffmann-La Roche Ag Modulators for amyloid beta
AU2009313524A1 (en) * 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
AU2009313527A1 (en) * 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
AU2009312856A1 (en) 2008-11-10 2010-05-14 F. Hoffmann-La Roche Ag Heterocyclic gamma secretase modulators
MX2011005046A (es) 2008-11-13 2011-06-01 Schering Corp Moduladores de gamma secretasa.
EP2401277A1 (en) 2009-02-26 2012-01-04 Eisai R&D Management Co., Ltd. Salt of tetrahydrotriazolopyridine derivative and crystal thereof
CA2753696A1 (en) 2009-02-26 2010-09-02 Noritaka Kitazawa Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
JP2012176901A (ja) * 2009-09-25 2012-09-13 Eisai R & D Management Co Ltd 新規ベンゾニトリル化合物およびその製造方法
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines
US20130095068A1 (en) * 2010-06-15 2013-04-18 Eisai R&D Management Co., Ltd. Agent for treating hcv infection
JP6095208B2 (ja) * 2012-12-04 2017-03-15 学校法人慶應義塾 環化化合物の製造方法、及び、環化化合物を含有する溶液の発光方法
JP7208137B2 (ja) * 2016-12-09 2023-01-18 デナリ セラピューティクス インコーポレイテッド 化合物、組成物および方法
JP7140781B2 (ja) 2017-05-17 2022-09-21 デナリ セラピューティクス インコーポレイテッド 化合物、組成物および方法
KR20220079878A (ko) * 2019-10-07 2022-06-14 디.이. 쇼우 리서치, 엘엘씨 Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로비시클릭 화합물

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508718A (en) 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
ES2061432T3 (es) 1985-10-09 1994-12-16 Shell Int Research Nuevas amidas de acido acrilico.
US4783463A (en) 1985-10-23 1988-11-08 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
DE3541716A1 (de) 1985-11-26 1987-05-27 Celamerck Gmbh & Co Kg Neue acrylsaeureamide
FI91754C (fi) 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
IT1205834B (it) * 1987-04-22 1989-03-31 Elbart Derivati tiodiossolanici ad attivita' mucolitica a procedimento per la loro preparazione
FI902321A7 (fi) 1989-05-19 1990-11-20 Eisai Co Ltd Buteenihappojohdannaiset
JPH03206042A (ja) 1990-01-06 1991-09-09 Takeda Chem Ind Ltd 降圧剤
ES2100943T3 (es) 1990-02-08 1997-07-01 Eisai Co Ltd Derivado de bencenosulfonamida.
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
GB9402807D0 (en) 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
KR970706242A (ko) 1994-10-04 1997-11-03 후지야마 아키라 우레아 유도체 및 ACAT-억제제로서 그의 용도(Urea derivatives and their use as ACAT-inhibitors)
JPH08283219A (ja) 1995-04-07 1996-10-29 Eisai Co Ltd アラルキルアミノアルキルアミド誘導体
BR9709230A (pt) 1996-05-10 1999-08-10 Icos Corp Composto
JP2000515153A (ja) 1996-07-22 2000-11-14 モンサント カンパニー チオールスルホンアミド メタロプロテアーゼインヒビター
JP2001508767A (ja) 1996-12-02 2001-07-03 藤沢薬品工業株式会社 ５―ｈｔ拮抗作用を有するインドール―ウレア誘導体
JP3108997B2 (ja) 1997-03-31 2000-11-13 武田薬品工業株式会社 アゾール化合物、その製造法および用途
CN1251098A (zh) 1997-03-31 2000-04-19 武田药品工业株式会社 吡咯化合物,其制备及其用途
TW379224B (en) 1997-12-02 2000-01-11 Fujisawa Pharmaceutical Co Urea derivatives
AU754965B2 (en) * 1997-12-31 2002-11-28 University Of Kansas, The Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
GB9816984D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
US6235728B1 (en) * 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
NZ514453A (en) 1999-02-26 2003-04-29 Merck & Co Inc Novel sulfonamide compounds and uses thereof
US7053087B1 (en) * 1999-03-04 2006-05-30 Cardiome Pharma Corp. Aminocycloalkyl cinnamide compounds for arrhythmia and analgesics and anesthetics
AU2001241128A1 (en) 2000-03-14 2001-09-24 Fujisawa Pharmaceutical Co. Ltd. Novel amide compounds
US20010051642A1 (en) * 2000-04-17 2001-12-13 Kyunghye Ahn Method for treating Alzheimer's disease
WO2001081312A2 (en) 2000-04-24 2001-11-01 Merck Frosst Canada & Co. Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
WO2002046166A1 (en) * 2000-12-04 2002-06-13 F. Hoffmann-La Roche Ag Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
GB0108770D0 (en) * 2001-04-06 2001-05-30 Eisai London Res Lab Ltd Inhibitors
WO2003022273A1 (en) 2001-09-13 2003-03-20 Boehringer Ingelheim Pharmaceuticals, Inc. Methods of treating cytokine mediated diseases
CA2460541A1 (en) 2001-09-14 2003-04-03 Helle Birk Olsen Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
JP2005518371A (ja) 2001-12-10 2005-06-23 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療に於けるこれらの使用
CA2471099C (en) 2001-12-20 2011-04-12 Bristol-Myers Squibb Company .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
JP2003206280A (ja) 2001-12-28 2003-07-22 Takeda Chem Ind Ltd ビアリール化合物およびその用途
EP1509505A2 (en) 2002-01-23 2005-03-02 Arena Pharmaceuticals, Inc. SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
GB0207436D0 (en) 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
MXPA04011472A (es) * 2002-05-22 2005-02-14 Amgen Inc Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor.
WO2003101927A1 (en) * 2002-05-31 2003-12-11 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US7459476B2 (en) * 2002-06-27 2008-12-02 Elan Pharmaceuticals, Inc. Methods for treating Alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
MXPA05000053A (es) 2002-07-12 2005-04-08 Aventis Pharma Gmbh Benzoilureas heterociclicamente sustituidas, metodo para su produccion y su uso como medicamentos.
US6900354B2 (en) * 2002-07-15 2005-05-31 Hoffman-La Roche Inc. 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
CA2514363A1 (en) 2003-02-12 2004-08-26 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
WO2004110350A2 (en) * 2003-05-14 2004-12-23 Torreypines Therapeutics, Inc. Compouds and uses thereof in modulating amyloid beta
EP1663204B1 (en) 2003-08-29 2014-05-07 Exelixis, Inc. C-kit modulators and methods of use
EA010132B1 (ru) 2003-12-22 2008-06-30 Пфайзер Инк. Производные триазола в качестве антагонистов вазопрессина
WO2005072731A1 (en) 2004-01-29 2005-08-11 X-Ceptor Therapeutics, Inc. 3-phenyl-n- ((1, 3, 4) thiadiazol-2-yl) -acrylamide derivatives and related compounds as modulators of estrogen-related receptors for the treatment of e.g. cancer, rheumatoid arthritis or neurological disorders
CA2551909C (en) 2004-02-12 2011-10-11 Transtech Pharma, Inc. Substituted azole derivatives, compositions, and methods of use
RU2361872C2 (ru) 2004-05-26 2009-07-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Циннамидное соединение
EP1786422A2 (en) 2004-08-16 2007-05-23 Prosidion Limited Aryl urea derivatives for treating obesity
DE602005019602D1 (de) 2004-10-26 2010-04-08 Eisai R&D Man Co Ltd Amorphe form einer zimtsäureamidverbindung
US20060241038A1 (en) 2005-04-20 2006-10-26 Eisai Co., Ltd. Therapeutic agent for Abeta related disorders
WO2007034282A2 (en) 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists
CN101309916A (zh) * 2005-11-18 2008-11-19 卫材R&D管理有限公司 制备肉桂酰胺衍生物的方法
US20090048448A1 (en) * 2005-11-18 2009-02-19 Ikuo Kushida Salts of cynnamide compound or solvates thereof
KR20080069221A (ko) * 2005-11-24 2008-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 모르폴린 타입의 신나미드 화합물
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
US20070117839A1 (en) * 2005-11-24 2007-05-24 Eisai R&D Management Co., Ltd. Two cyclic cinnamide compound
TWI378091B (en) * 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
AR059955A1 (es) 2006-03-09 2008-05-14 Eisai R&D Man Co Ltd Compuestos policiclicos no peptidicos, medicamentos que los contienen, y usos para prevenir o tratar enfermedades causadas por la produccion de beta amiloide
US7737141B2 (en) * 2006-07-28 2010-06-15 Eisai R&D Management Co., Ltd. Prodrug of cinnamide compound
JP2010518080A (ja) 2007-02-08 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション 治療薬
WO2008137102A2 (en) 2007-05-04 2008-11-13 Torreypines Therapeutics, Inc. Methods of modulating amyloid beta and compounds useful therefor
RU2009144998A (ru) 2007-05-07 2011-06-20 Шеринг Корпорейшн (US) Модуляторы гамма-секретазы
KR101138045B1 (ko) * 2007-05-11 2012-04-24 에프. 호프만-라 로슈 아게 아밀로이드 베타에 대한 조절제로서의 헤트아릴아닐린
EP2166854A4 (en) 2007-06-13 2012-05-16 Merck Sharp & Dohme TRIAZONE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER AND RELATED SUFFERINGS
CA2695543A1 (en) 2007-08-06 2009-02-12 Schering Corporation Gamma secretase modulators

Also Published As

Publication number Publication date
PL1953158T3 (pl) 2013-02-28
NO20082805L (no) 2008-08-20
CA2629512A1 (en) 2007-05-31
TWI370130B (en) 2012-08-11
JP5178203B2 (ja) 2013-04-10
WO2007060821A1 (ja) 2007-05-31
KR20080072057A (ko) 2008-08-05
EA014427B1 (ru) 2010-12-30
BRPI0618890A2 (pt) 2013-01-08
JPWO2007060821A1 (ja) 2009-05-07
AU2006317468A1 (en) 2007-05-31
KR101296239B1 (ko) 2013-08-13
EA200801417A1 (ru) 2009-02-27
PE20071029A1 (es) 2007-11-17
US8048878B2 (en) 2011-11-01
AR057915A1 (es) 2007-12-26
EP1953158A4 (en) 2010-09-01
EP1953158A1 (en) 2008-08-06
EP1953158B1 (en) 2012-09-12
AU2006317468B2 (en) 2011-10-13
MY144596A (en) 2011-10-14
HN2008000792A (es) 2010-09-17
RS20080242A (sr) 2009-09-08
CA2629512C (en) 2014-04-22
MA29968B1 (fr) 2008-11-03
NZ568422A (en) 2010-09-30
CR9983A (es) 2008-08-21
GEP20115172B (en) 2011-03-10
US20090181945A1 (en) 2009-07-16
ES2394364T3 (es) 2013-01-31
TW200804372A (en) 2008-01-16
SA06270432B1 (ar) 2011-06-22
ME00040B (me) 2010-06-10
HK1122806A1 (en) 2009-05-29

Similar Documents

Publication Publication Date Title
ECSP088466A (es) Compuesto de cinamida biciclico
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
DK1992618T3 (da) Polycyklisk cinnamidderivat
ECSP099091A (es) Profarmaco de compuesto de cinamida
EA201101026A1 (ru) Ингибиторы бета-секретазы
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
TW200738688A (en) Compounds for the treatment of inflammatory disorders
AR077080A1 (es) Compuestos de 2,3-dihidro-1h-indeno
CR10383A (es) Derivados triazolopirazina.
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
EA201170282A1 (ru) Фунгицидные n-циколоалкил-n-бифенилметилкарбоксамидные производные
ES2657549T3 (es) Piridopirazinas sustituidas como nuevos inhibidores de SYK
UY28700A1 (es) Compuestos
DK2190426T3 (da) Griseofulvin-analoger til behandling af cancer ved hæmning af centrosomal clusterdannelse
NO20085107L (no) Spirosykliske nitriler som proteaseinhibitorer
EA201070467A1 (ru) Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
ITBO20050696A1 (it) Macchina per la produzione di filtri composti
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav
ATE501103T1 (de) Organische verbindungen
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
EA201001566A1 (ru) Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
DK2046754T3 (da) Fremgangsmåde til fremstilling af alkylanilider ud fra halogenbenzenderivater
ECSP088374A (es) Formulacion de aerosol para inhalacion
NO20076161L (no) Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner